三阴性乳腺癌治疗“中国方案”首发 - 2020年04月13日

Experts from the Shanghai Cancer Center have announced a new combined chemotherapy treatment targeting the toughest type of breast cancer is able to improve the five-year disease-free survival rate by almost 6 percentage points to 86.3 percent, and reduce the risk of relapse by 41 percent.
The study was published in the world leading Journal of Clinical Oncology.
Breast cancer has become a preventable and treatable chronic disease as a result of early screening, as well as improvements in surgery and targeted medication.